Golden State Equity Partners’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Buy |
391,943
+20,000
| +5% | +$10.8K | 0.04% | 403 |
|
|
2025
Q1 | $244K | Buy |
371,943
+46,259
| +14% | +$30.3K | 0.05% | 373 |
|
|
2024
Q4 | $332K | Buy |
325,684
+313,587
| +2,592% | +$320K | 0.06% | 316 |
|
|
2024
Q3 | $10.5K | Sell |
12,097
-185,019
| -94% | -$160K | 0.01% | 573 |
|
|
2024
Q2 | $70.6K | Buy |
+197,116
| New | +$70.6K | 0.01% | 398 |
|
|
2023
Q4 | $109K | Buy |
201,225
+34,960
| +21% | +$19K | 0.03% | 352 |
|
|
2023
Q3 | $99.7K | Buy |
166,265
+30,500
| +22% | +$18.3K | 0.03% | 330 |
|
|
2023
Q2 | $176K | Hold |
135,765
| – | – | 0.05% | 351 |
|
|
2023
Q1 | $239K | Buy |
+135,765
| New | +$239K | 0.13% | 177 |
|
|
2022
Q1 | $897K | Buy |
154,360
+10,592
| +7% | +$61.6K | 0.45% | 66 |
|
|
2021
Q4 | $1.08M | Buy |
143,768
+16,203
| +13% | +$121K | 0.54% | 46 |
|
|
2021
Q3 | $1.15M | Buy |
127,565
+257
| +0.2% | +$2.32K | 0.47% | 49 |
|
|
2021
Q2 | $1.52M | Buy |
127,308
+700
| +0.6% | +$8.38K | 0.59% | 37 |
|
|
2021
Q1 | $1.59M | Buy |
126,608
+2,791
| +2% | +$35K | 0.91% | 31 |
|
|
2020
Q4 | $1.93M | Buy |
+123,817
| New | +$1.93M | 1.33% | 16 |
|